2024-11-27  6:40:44 PM Chg. - Volume Bid- Ask- Market Capitalization Dividend Y. P/E Ratio
34.6550USD - 150
Turnover: 5,198.2500
-Bid Size: - -Ask Size: - 19.41 bill.USD - -

Business description

Fresenius is a health care group with international operations, providing products and services for dialysis, hospital and outpatient medical care.
 

Management board & Supervisory board

CEO
Michael Sen
Management board
Sara Hennicken, Pierluigi Antonelli , Robert Möller, Michael Moser
Supervisory board
Wolfgang Kirsch, Prof. Dr. D. Michael Albrecht, Stefanie Balling , Bernd Behlert , Michael Diekmann , Grit Genster , Konrad Kölbl , Frauke Lehmann , Prof. Dr. med. Iris Löw-Friedrich , Oscar Romero de Paco , Susanne Zeidler , Dr. Christoph Zindel , Holger Michel
 

Company data

Name: Fresenius SE & Co. KGaA
Address: Else-Kröner-Straße 1,D-61352 Bad Homburg
Phone: +49-6172-608-0
Fax: -
E-mail: pr-fre@fresenius.com
Internet: www.fresenius.de
Industry: Healthcare
Sector: Medical Products
Sub sector: Advanced Medical Devices
End of financial year: 12-31
Free Float: 56.49%
IPO date: 1986-12-18

Investor relations

Name: Markus Georgi
IR phone: +49-6172-608-2485
IR Fax: +49-6172-608-2488
IR e-mail: ir-fre@fresenius.com

Company calendar

CW 9 | 2025-02-26 Annual Report
CW 19 | 2025-05-07 Interim Report 1st Quarter/3 Months
CW 21 | 2025-05-23 General Shareholder Meeting
CW 32 | 2025-08-06 Interim Report 2nd Quarter/6 Months
CW 45 | 2025-11-05 Interim Report 3rd Quarter/9 Months